![[Updated] U.S. Air Force Mobilizes F-22s and F-35s as Situation in Middle East Escalates](https://theaviationist.com/wp-content/uploads/2025/06/F-22_F-35_CENTCOM-top.jpg)
![[Updated] Sudden Deployment of Dozens of U.S. Air Force Tankers Raises Questions](https://theaviationist.com/wp-content/uploads/2025/03/Stratotanker100Years_2-e1750080240327.jpg)
Immuneering sees 94% survival at 6 months in pancreatic cancer, teeing up pivotal trial plans
Immuneering has reported 94% overall survival at six months in first-line pancreatic cancer, emboldening the biotech to start planning a pivotal trial to support accelerated approval of its MEK inhibitor.
Immuneering has reported 94% overall survival at six months in first-line pancreatic cancer, emboldening the biotech to start planning a pivotal trial to support accelerated approval of its MEK inhibitor.
